Everolimus
Everolimus is a derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It has been approved by the FDA for use in the treatment of certain breast cancer, pancreatic cancer, renal cell cancer and other tumours. Also, it is used as an immunosuppressant to prevent rejection of organ transplants.
Product Name:
Everolimus
>Also Known As:
N/A
>Catalog No.:
F6140
>Size:
5 mg
>CAS:
159351-69-6
>Formula:
C53H83NO14
>Molecular Weight:
5958.22 Da
>Form:
Lyophilized powder
>Quality Assurance:
>98% by HPLC and NMR
>Source:
Synthetic
>Storage:
Eligible for room temperature shipping. Store at 2-8°C upon receiving
>PDF Data Sheet:
Download PDF datasheet
>Image(s):
N/A
>Shipping Method:
Room temperature shipping
>References:
Eisen HJ, et al. (2003). N. Engl. J. Med. 349 (9): 847–58. Firategrast 18480209
